We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$578B
AUM Growth
+$59.6B
Cap. Flow
+$35.2B
Cap. Flow %
6.08%
Top 10 Hldgs %
31.21%
Holding
15,826
New
1,745
Increased
6,428
Reduced
6,082
Closed
1,423

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$830M
2
UNH icon
UnitedHealth
UNH
+$769M
3
AJG icon
Arthur J. Gallagher & Co
AJG
+$691M
4
AMZN icon
Amazon
AMZN
+$654M
5
BAC icon
Bank of America
BAC
+$634M

Sector Composition

Rank Sector Weight
1 Healthcare 3.13%
2 Technology 2.97%
3 Financials 2.19%
4 Consumer Discretionary 2.09%
5 Industrials 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REK icon
15201
CALL
ProShares Short Real Estate
REK
$12M
-900
Closed -$14.5K
RFFC icon
15202
ALPS Active Equity Opportunity ETF
RFFC
$30.9M
-5,187
Closed -$299K
RFG icon
15203
Invesco S&P MidCap 400 Pure Growth ETF
RFG
$362M
-12,235
Closed -$602K
RGLS
15204
CALL
DELISTED
Regulus Therapeutics
RGLS
-29,200
Closed -$45.8K
RLAY icon
15205
CALL
Relay Therapeutics
RLAY
$4.39B
-1,500
Closed -$10.6K
RLMD icon
15206
Relmada Therapeutics
RLMD
$502M
-52,846
Closed -$129K
RNR icon
15207
RenaissanceRe
RNR
$13.2B
-20,937
Closed -$5.62M
RNST icon
15208
PUT
Renasant Corp
RNST
$3.94B
-100
Closed -$3.25K
ROBT icon
15209
First Trust Nasdaq Artificial Intelligence and Robotics ETF
ROBT
$779M
-49,842
Closed -$2.18M
RODE
15210
DELISTED
Hartford Multifactor Diversified International ETF
RODE
-23,184
Closed -$693K
ROKT icon
15211
State Street SPDR S&P Kensho Final Frontiers ETF
ROKT
$217M
-9,294
Closed -$470K
ROMO icon
15212
Strategy Shares Newfound/ReSolve Robust Momentum ETF
ROMO
$25.8M
-6,839
Closed -$215K
RPTX
15213
DELISTED
Repare Therapeutics
RPTX
-102,860
Closed -$354K
RPTX
15214
PUT
DELISTED
Repare Therapeutics
RPTX
-300
Closed -$1.03K
RSPC icon
15215
Invesco S&P 500 Equal Weight Communication Services ETF
RSPC
$57M
-9,027
Closed -$295K
RSVR
15216
PUT
Reservoir Media
RSVR
$657M
-5,000
Closed -$40.5K
RULE icon
15217
Adaptive Core ETF
RULE
$16.1M
-18,939
Closed -$414K
RUNN icon
15218
Strategic Trust Running Oak Efficient Growth ETF
RUNN
$408M
-27,995
Closed -$936K
RUSHB icon
15219
Rush Enterprises Class B
RUSHB
$9.11B
-15,256
Closed -$732K
RVMDW icon
15220
Revolution Medicines Inc Warrant
RVMDW
$127M
-23,660
Closed -$3.31K
RVP icon
15221
PUT
Retractable Technologies
RVP
$20.3M
-100
Closed -$77
RVPH
15222
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
-675
Closed -$18.8K
SABS icon
15223
SAB Biotherapeutics
SABS
$346M
-10,305
Closed -$27.8K
SACH
15224
Sachem Capital Corp
SACH
$39.1M
-25,096
Closed -$63.2K
SACH
15225
PUT
Sachem Capital Corp
SACH
$39.1M
-2,700
Closed -$6.8K

Similar funds

Citadel Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.

  • Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
  • Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
  • Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
  • Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
  • Citadel Advisors opened 1,745 new positions and closed 1,423 in Q4 2024.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.